Insights & News
Discover more about ProPharma and how its dedicated team of industry-leading experts supports clients at every step through the product lifecycle.
Thought Leadership
ProPharma’s team of dedicated experts provides strategic guidance across the entire product lifecycle, helping pharmaceutical, biotechnology, and medical device companies navigate complex challenges with confidence. By leveraging deep industry expertise and data-driven insights, we deliver tailored solutions that support regulatory compliance, clinical development, and patient safety.
Turning Regulatory Complexity into Predictable Study Start-Up Execution
Regulatory complexity is unavoidable in global clinical development. The differentiator is not whether organizations face complexity, it is how effectively they operationalize it. Across Europe, study start-up teams are now operating in an environment where speed expectations continue to rise while...
Regulatory Readiness as a Strategic Advantage in European Study Start-Up
For years, regulatory readiness was often viewed primarily as a compliance function, an operational necessity required to move clinical studies forward. Today, that perspective is no longer sufficient. In modern global development programs, regulatory readiness has evolved into a strategic...
Successful Tech Transfers Require Both Strong Regulatory Strategy and Execution
Tech transfers are often treated as operational projects. In reality, the success, and especially the speed, are determined much earlier: by the clarity of your data requirements and gaps, your CMC strategy, and the strength of your Module 3. Too much focus is placed on execution and not enough on...
Resources
ProPharma is committed to delivering dynamic research and perspectives crafted by world-class subject matter experts. ProPharma provides valuable insights to its clients to enable thoughtful decision making, as well as informed resource & investment allocation.
Meeting Patients Where They Are: Delivering Global Clinical Support for Time-Sensitive Research
Conducting clinical research for rare pediatric populations presents unique operational challenges, particularly when eligible patients may be born anywhere in the world and require immediate identification, screening, and enrollment. Ensuring consistent protocol execution while coordinating care...
Accelerating Commercial Readiness for a Novel Cell Therapy Program
As advanced therapy developers move from research-stage operations toward commercialization, they often face significant challenges in scaling quality systems, aligning regulatory strategy, and building inspection-ready infrastructure without delaying critical submission milestones. A sponsor...
Keeping Research Moving Under Pressure: Delivering Data Integrity at Speed
When patient enrollment rapidly exceeds expectations, clinical trials can face significant operational strain, putting data integrity, timelines, and critical sponsor decisions at risk. A mid-size biotech sponsor conducting parallel Phase 2 respiratory studies experienced accelerated enrollment...
Press Room
ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as a pharmaceutical and MedTech service provider. Stay up to date on ProPharma's latest news and most recent announcements.
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development
New proprietary capability enhances ProPharma's regulatory service delivery model, helping clients accelerate submission development while maintaining the highest standards of quality and compliance. RALEIGH, July 8, 2026 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities
ProPharma is excited to welcome Kevin van Dooren as Vice President, Health Economics and Outcomes Research (HEOR) and Market Access, to our Regulatory Sciences team. The addition of Kevin marks a significant step forward in our commitment to delivering fully integrated regulatory and market access...
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization RALEIGH, N.C. – May 27, 2026 – ProPharma, a leading provider of regulatory, clinical, and compliance services for the life sciences industry, today announced the appointment of Adrian Pencak as Chief Commercial Officer....
Awards
With over 20 years of proven success, ProPharma continues to be acknowledged within the life sciences industry for providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. ProPharma proudly shares its recognition and achievements as its team works to improve the health and safety of patients.
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development
New proprietary capability enhances ProPharma's regulatory service delivery model, helping clients accelerate submission development while maintaining the highest standards of quality and compliance. RALEIGH, July 8, 2026 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities
ProPharma is excited to welcome Kevin van Dooren as Vice President, Health Economics and Outcomes Research (HEOR) and Market Access, to our Regulatory Sciences team. The addition of Kevin marks a significant step forward in our commitment to delivering fully integrated regulatory and market access...
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization RALEIGH, N.C. – May 27, 2026 – ProPharma, a leading provider of regulatory, clinical, and compliance services for the life sciences industry, today announced the appointment of Adrian Pencak as Chief Commercial Officer....
Overcoming Challenges. Advancing Patient Care.
Bringing new therapies to market is more complex than ever. ProPharma helps you navigate regulatory challenges with expert guidance, ensuring compliance and accelerating patient access to life-changing treatments.